Hepatitis C immune globulin (Biotest Pharmaceuticals)

N/A

Report date: 2024/06/27 20:00:09

Base Information

Drug NameHepatitis C immune globulin (Biotest Pharmaceuticals)
Drug Alias NameBoca HBVIg (Biotest)Hepatitis C Immune Globulin Intravenous (Human) 5% (Biotest Pharmaceuticals)CivacirHCVIG
ClassificationBiologics > Protein drugs > ImmunoglobulinBiologics > Blood components
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNabi Biopharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiotest Pharmaceuticals Co
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A